MedTech News

Breathing in 4D: Optical technique maps airway wall elasticity during bronchoscopy
Scientists have developed a faster method for measuring the elasticity of airway walls, a property that can reveal important information about respiratory health.

Immunotherapy helps extend the lives of patients with rare form of skin cancer
A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system attack cancer cells, can effectively shrink or eliminate tumors in patients with unresectable advanced desmoplastic melanoma, a rare and often aggressive form of skin cancer.

Brain-computer interface shows promise for decoding inner speech in real time
Scientists have pinpointed brain activity related to inner speech—the silent monolog in people’s heads—and successfully decoded it on command with up to 74% accuracy.

Researchers discover the immune system’s ‘fountain of youth’—though it comes at a price
The immune system is meant to protect the body from infection and disease. But with age, it can become less capable of doing so. However, Mayo Clinic researchers have found that some older people maintain “immune youth”—a new term coined by Mayo researchers to explain a young immune system in someone over age 60.

Smoking cessation app with real-time support nearly doubles quit rates in clinical trial
A smartphone app that delivers real-time, tailored messages may hold the key to helping them quit, according to University of Oklahoma clinical trial results published in JAMA Network Open.

AI finds more breast tumors earlier than traditional double radiologist review
This has been demonstrated by researchers led by Radboud university medical center in a study published in The Lancet Digital Health

Cancer drug eliminates aggressive cancers in Phase I trial
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment.

Novel monoclonal antibody targets deadly sepsis by preventing ‘cytokine storms’
Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection.